Treatment with paromomycin (25-35 mg/kg/d for 7 days) was evaluated prospectively in 15 children with Dientamoeba fragilis infection after 1-month follow-up. At the end of the study, parasitologic effectiveness and clinical improvement were observed in 12/15 (80%) and 13/15 (87%) patients, respectively. Paromomycin appears to be an effective drug for treatment of D. fragilis infection in children.
No takes yet. Share an insight, caveat, or question.
Vandenberg et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: